Virtus Investment Advisers, Inc. Mereo Biopharma Group PLC Transaction History
Virtus Investment Advisers, Inc.
- $327 Million
- Q3 2025
A detailed history of Virtus Investment Advisers, Inc. transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 40,930 shares of MREO stock, worth $74,492. This represents 0.02% of its overall portfolio holdings.
Number of Shares
40,930
Previous 33,825
21.01%
Holding current value
$74,492
Previous $91,000
10.99%
% of portfolio
0.02%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding MREO
# of Institutions
96Shares Held
99.9MCall Options Held
2.23MPut Options Held
179K-
Janus Henderson Group PLC London, X016.3MShares$29.6 Million0.02% of portfolio
-
Rubric Capital Management LP New York, NY15.3MShares$27.9 Million0.5% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA9.44MShares$17.2 Million0.79% of portfolio
-
Mangrove Partners New York, NY7.79MShares$14.2 Million1.99% of portfolio
-
Abrdn PLC5.54MShares$10.1 Million0.02% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $227M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...